Lifeline Skin Care Grows Its Human Stem-Cell Anti-Aging Line
This article was originally published in The Rose Sheet
Executive Summary
Lifeline Skin Care expands its offerings with an eye treatment featuring its patented stem-cell extract. Exec Linda Nelson explained International Stem Cell Corporation’s technology and its applications for Lifeline at the recent SupplySide West conference.
You may also be interested in...
Stemology Anti-Aging Line Leverages Stem Cells From Humans, Plants
“Healing peptide” from adult human stem cells, plant stem cells and an intercellular communication enhancer make up the proprietary StemCore-3 technology in Dermatech Research’s Stemology skin-care line. Products in the collection range from $189 for Cell Revive Serum Complete to $19 for cleansing items.
FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?
L’Oreal/Lancome’s claims for Genifique anti-aging products, among others, identify the products as drugs under food and drug law, according to FDA’s Sept. 7 warning letter. Agency cites claims suggesting the brand’s technology “boosts the activity of genes” and “improve[s] the condition around the stem cells” – language that is not altogether unique in today’s anti-aging cosmeceutical market.
Lifeline For Aging Consumers: A Chat With International Stem Cell Corp's CEO
Oceanside, Calif.-based International Stem Cell Corporation recently announced that Lifeline Skin Care, an anti-aging range based on the biotechnology firm's parthenogenetic stem-cell technology, is available to the public through the brand's website following a soft debut in November.